Vaccher, Stefanie J.
Marzinke, Mark A.
Templeton, David J.
Haire, Bridget G.
Ryder, Nathan
McNulty, Anna
Foster, Rosalind
Grulich, Andrew E.
Zablotska, Iryna B.
Bloch, Mark
Carr, Andrew
Cheung, Ching
Foster, Rosalind
Gianacas, Christopher
Grulich, Andrew
Guy, Rebecca
Holt, Martin
Kaldor, John
Mackie, Brent
Mayer, Kenneth
McAllister, John
McNulty, Anna
Murphy, Dean
Ooi, Catriona
Pell, Cathy
Poynten, Isobel M.
Prestage, Garrett
Ryder, Nathan
Templeton, David
Vaccher, Stefanie
de Wit, John
Wright, Edwina
Zablotska, Iryna
Callander, Denton
Cooper, David
Cooper, Craig
Crooks, Levinia
Duck, Tim
Grulich, Andrew
Guy, Rebecca
Holden, Jo
Holt, Martin
Kaldor, John
Keen, Phillip
Kelleher, Anthony
Mitchell, Jo
Prestage, Garrett
Price, Karen
Selvey, Christine
Schmidt, Heather-Marie
Telfer, Barbara
Whittaker, Bill
Wilson, David
de Wit, John
Zablotska, Iryna
,
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Predictors of Daily Adherence to HIV Pre-exposure Prophylaxis in Gay/Bisexual Men in the PRELUDE Demonstration Project
https://doi.org/10.1007/s10461-018-2353-5
Funding for this research was provided by:
National Health and Medical Research Council (1092852)
NSW Ministry of Health
University of New South Wales
Gilead Sciences
Article History
First Online: 6 December 2018
Compliance with Ethical Standards
:
: AEG has research funding from Seqirus, Gilead, Viiv, and in-kind research support from Hologic. He has received travel funding from Gilead. IBZ has received research funding and in-kind support (supply of the study medication) from Gilead Sciences Inc. Authors SJV, MAM, BGH, DJT, NR, AM, and RF declare that they have no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.